VASCULAR INFLAMMATION IN ATHEROSCLEROSIS: THE MECHANISMS OF THE NLRP3 INFLAMMASOME IN THE GENESIS OF ATHEROSCLEROTIC PLAQUE INSTABILITY
Health and Society · 07.08.2026 · 6 (04) · 222-236
DOI: 10.51249/hs.v6i04.3134 ↗Kurz gefasst
Fachartikel in der Zeitschrift Health and Society, online erschienen am 07.08.2026. Verfasst von Luiz Coelho Soares Figueiredo und 12 weiteren Autor:innen. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Atherosclerosis is a chronic inflammatory disease characterized by lipid accumulation and inflammatory cell infiltration within the arterial wall, representing the leading cause of cardiovascular diseases worldwide. Recent evidence has demonstrated that the NLRP3 inflammasome plays a central role in the inflammatory response responsible for atherosclerosis progression and atherosclerotic plaque instability.
Objective
To analyze the mechanisms by which the NLRP3 inflammasome contributes to vascular inflammation and the development of unstable atherosclerotic plaques, as well as to discuss its potential as a therapeutic target.
Methods
This is a descriptive, exploratory, qualitative narrative literature review conducted using PubMed/MEDLINE, Scopus, Web of Science, and the Virtual Health Library (VHL). Controlled descriptors related to atherosclerosis, the NLRP3 inflammasome, and vascular inflammation were employed. After applying the eligibility criteria, 20 studies were included in the qualitative analysis. Results and discussion: The selected studies demonstrated that activation of the NLRP3 inflammasome by cholesterol crystals, reactive oxygen species, and other danger signals promotes caspase-1 activation and the release of IL-1β and IL-18, amplifying vascular inflammation. This process contributes to foam cell formation, extracellular matrix degradation, fibrous cap thinning, and plaque instability. Furthermore, experimental and clinical evidence indicates that anti-inflammatory therapies targeting the NLRP3 pathway reduce cardiovascular events, highlighting the translational potential of this therapeutic strategy.
Conclusion
The NLRP3 inflammasome is a key mediator of atherosclerosis progression and plaque instability, representing both a promising biomarker and a potential therapeutic target for preventing cardiovascular complications. Further studies are needed to optimize diagnostic and therapeutic approaches aimed at modulating vascular inflammation.
Zitieren
APA
Figueiredo, L. C. S., Figueiredo, B. D. O., Santos, V. G. D., Jório, C. H. C. N., Gonçalves, G. A., Albani, M. C., Vieira, I. D. S., Batista, M. V. D. S., Daflon, A. L. L. G., Braga, M. M. P., Simões, A. V., Oliveira, C. L. C., & Figueiredo, G. C. S. (2026). VASCULAR INFLAMMATION IN ATHEROSCLEROSIS: THE MECHANISMS OF THE NLRP3 INFLAMMASOME IN THE GENESIS OF ATHEROSCLEROTIC PLAQUE INSTABILITY. Health and Society, 6(04), 222-236. https://doi.org/10.51249/hs.v6i04.3134
Vancouver
Figueiredo LCS, Figueiredo BDO, Santos VGD, Jório CHCN, Gonçalves GA, Albani MC, et al. VASCULAR INFLAMMATION IN ATHEROSCLEROSIS: THE MECHANISMS OF THE NLRP3 INFLAMMASOME IN THE GENESIS OF ATHEROSCLEROTIC PLAQUE INSTABILITY. Health and Society. 2026;6(04):222-236. doi:10.51249/hs.v6i04.3134
BibTeX
@article{Figueiredo2026,
author = {Figueiredo, Luiz Coelho Soares and Figueiredo, Bruno De Oliveira and Santos, Valdinei Gonçalves dos and Jório, Catarina Helena Costa Nunes and Gonçalves, Gabriela Amaral and Albani, Marcelo Costa and Vieira, Isabela Da Silva and Batista, Milene Vargas da Silva and Daflon, Ana Luiza Latini Girolamy and Braga, Mariana Manhães Pinto and Simões, Arthur Valiatti and Oliveira, Claudete Lúcia Carvalho and Figueiredo, Gabriela Coelho Soares},
title = {VASCULAR INFLAMMATION IN ATHEROSCLEROSIS: THE MECHANISMS OF THE NLRP3 INFLAMMASOME IN THE GENESIS OF ATHEROSCLEROTIC PLAQUE INSTABILITY},
journal = {Health and Society},
year = {2026},
volume = {6},
number = {04},
pages = {222--236},
doi = {10.51249/hs.v6i04.3134}
}
EUVIMED